Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 68, Issue 6, 1989, Pages 1027-1032

  Nestler, John E ^a   Barlascini, Cornelius O ^a   Matt, Dennis W ^a   Steingold, Kenneth A ^a   Plymate, Stephen R ^b   Clore, John N ^a   Blackard, William G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; FOLLITROPIN; GONADORELIN; INSULIN; LUTEINIZING HORMONE; TESTOSTERONE;

CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

BLOOD GLUCOSE; DIAZOXIDE; FEMALE; FOLLICLE STIMULATING HORMONE; GONADORELIN; HUMAN; HYPERINSULINISM; INSULIN; LUTEINIZING HORMONE; OBESITY; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TESTOSTERONE;

EID: 0024381472     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-68-6-1027     Document Type: Article

References (34)

1. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandro-genism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50:113-6.
2. Shoupe D, Kumar DD, Lobo RA. Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol. 1983;147:588-92.
3. Chang RJ, Nakaruma RM, Judd HL, Kaplan SA. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983;57:356-9.
4. Gibson M, Schiff I, Tulchinsky D, Ryan KJ. Characterization of hyperandrogenism with insulin-resistant diabetes type A. Fertil Steril. 1980;33:501-5.
5. Kahn CR, Flier JS, Bar RS, et al. The syndrome of insulin resistance and acanthosis nigricans. N Engl J Med. 1976;294:739-45.
6. Taylor SI, Dons RF, Hernandez E, Roth J, Gorden P. Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. Ann Intern Med. 1982;97:851-5.
7. D’Ercole AJ, Underwood LE, Groelke J, Piet A. Leprechaunism: studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation. J Clin Endocrinol Metab. 1979;48:495-502.
8. Taylor SI. Receptor defects in patients with extreme insulin resistance. Diabetes/Metab Rev. 1985;1:171-202.
9. Rabson SM, Mendenhall EN. Familial hypertrophy of the pineal body, hyperplasia of the adrenal cortex and diabetes mellitus: report of three cases. Am J Clin Pathol. 1956;26:282-90.
10. Barbiéri RL, Ryan KJ. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol. 1983;147:90-101.
11. Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocr Rev. 1987;8:132-41.
12. Nestler JE, Clore JN, Strauss III JF, Blackard WG. The effects of hyperinsulinemia on serum testosterone, progesterone, déhydroépiandrostérone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab. 1987;64:180-4.
13. Veldhuis JD, Nestler JE, Strauss III JF, Gwynne JT. Insulin regulates low-density lipoprotein metabolism by swine granulosa cells. Endocrinology. 1986;118:2242-53.
14. Blanco FL, Fanjul LF, Ruiz de Galaretta CM. The effect of insulin and luteinizing hormone treatment on serum concentrations of testosterone and dihydrotestosterone and testicular 3β-hydroxyste-roid dehydrogenase activity in intact and hypophysectomized diabetic rats. Endocrinology. 1981;109:1248-53.
15. Garzo VG, Dorrington JH. Aromatase activity in human granulosa cells during follicular development and the modulation of follicle-stimulating hormone and insulin. Am J Obstet Gynecol. 1984;148:657-62.
16. Nestler JE. Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotropho-blasts by insulin and insulin-like growth factor I. Endocrinology. 1987;121:1845-52.
17. Barbiéri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986;62:904-10.
18. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-57.
19. Morgan CR, Lazarow A. Immunoassay of insulin: two antibody system. Diabetes. 1963;12:115-26.
20. Resko JA, Ellinwood WE, Pasztor LM, Buhl AE. Sex steroids in the umbilical circulation of fetal rhesus monkeys from the time of gonadal differentiation. J Clin Endocrinol Metab. 1980;50:900-5.
21. Nestler JE, Barlascini CO, Clore JN, Blackard WG. Déhydroépiandrostérone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 1988;66:57-61.
22. Plymate SR, Fariss BL, Bassett ML, Matej L. Obesity and its role in polycystic ovary syndrome. J Clin Endocrinol Metab. 1981;52:1246-48.
23. Sodergard R, Backstrom T, Shanbhag V, Cartensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem. 1982;16:801-10.
24. Veldhuis JD, Rogol AD, Johnson ML. Minimizing false-positive error rates in hormone pulse detection. Am J Physiol. 1985;248:E475-81.
25. McKenna TJ. Pathogenesis and treatment of polycystic ovary syndrome. N Engl J Med. 1988;318:558-62.
26. Dunaif A, Mandeli J, Fluhr H, Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1988;66:131-9.
27. Dunaif A, Graf M, Laumas V, Dobrjansky A. Insulin infusion increases androgen and estrogen production in polycystic ovary syndrome but not in normal women [Abstract]. Proc of the 69th Annual Meeting of the Endocrine Society; 1987;233.
28. Stuart CA, Prince NJ, Peters EJ, Meyer WJ. Hyperinsulinemia and hyperandrogenemia: in vivo response to insulin infusion. Obstet Gynecol. 1987;69:921-5.
29. Smith S, Ravnikar VA, Barbiéri RL. Androgen and insulin response to an oral glucose challenge in hyperandrogénie women. Fertil Steril. 1987;48:72-7.
30. Burr IM, Marliss EB, Stauffacher W, Renold AE. Diazoxide effects on biphasic insulin release: “adrenergic” suppression and enhancement in the perfused rat pancreas. J Clin Invest. 1971;50:1444-50.
31. Zarday Z, Viktora J, Wolff FW. The effect of diazoxide on catecholamines. Metabolism. 1966;15:257-61.
32. Haffner SM, Katz MS, Stern MP, Dunn JF. The relationship of sex hormones to hyperinsulinemia and hyperglycemia. Metabolism. 1988;37:683-8.
33. Franks S, Kiddy D, Scanlon MJ, et al. The influence of obesity on clinical and endocrine presentation in women with polycystic ovary syndrome (PCOS) [Abstract], Proc of the 70th Annual Meeting of The Endocrine Society; 1988:196.
34. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67:460-4.